P53 codon 72 polymorphism was associated with vulnerability, progression, but not prognosis of bladder cancer in a taiwanese population: An implication of structural equation modeling to manage the risks of bladder cancer

Urologia Internationalis

Volumn 86, Issue 3, 2011, Pages 355-360

  Lin, Hung Yu ^a,b   Huang, Chun Hsiung ^c   Yu, Tsan Jung ^a   Wu, Wen Jen ^c   Yang, Ming Chang ^d,e   Lung, For Wey ^c,d,f,g  

^a I SHOU UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^e NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^f NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^g Calo Psychiatric Center   (Taiwan)

Author keywords

Bladder cancer; p53 codon 72 polymorphism; Pro Pro genotype; Prognosis

Indexed keywords

PROTEIN P53;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER PATIENT; CANCER RISK; CODON; CONTROLLED STUDY; DISEASE COURSE; DNA SEQUENCE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STRUCTURAL EQUATION MODELING; TAIWAN;

AGED; CASE-CONTROL STUDIES; CODON; FEMALE; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGNOSIS; REGRESSION ANALYSIS; RISK; SEQUENCE ANALYSIS, DNA; TAIWAN; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 79955107009     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000323599     Document Type: Article

References (10)

1. Lung FW, Lee TM, Shu BC, Chang FH: p53 codon 72 polymorphism and susceptibility malignancy of colorectal cancer in Taiwan. J Cancer Res Clin Oncol 2004; 130: 728-732.
2. Furihata M, Kurabayashl A, Matsumoto M, Sonobe H, Ohtsuki Y, Terao N, Kuwahara M, Shuin T: Frequent phosphorylation at serine 392 in overexpressed p53 protein due to missense mutation in carcinoma of the urinary tract. J Pathol 2002; 197: 82-88. (Pubitemid 34450167)
3. Chen WC, Tsai FJ, Wu JY, Wu HC, Lu HF, Li CW: Distributions of p53 codon 72 polymorphism in bladder cancer-proline form is prominent in invasive tumor. Urol Res 2000; 28: 293-296.
4. Li CC, Chang TH, Wu WJ, Ke HL, Huang SP, Tsai PC, Chang SJ, Shen JT, Chou YH, Huang CH: Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Eur Urol 2008; 54: 1127-1134.
5. Soulitzis N, Sourvinos G, Dokianakis DN, Spandidos DA: p53 codon 72 polymorphism and its association with bladder cancer. Cancer Lett 2002; 179: 175-183. (Pubitemid 34215109)
6. Chen YC, Xu L, Guo YL, Su HJ, Smith TJ, Ryan LM, Lee MS, Christiani DC: Polymorphisms in GSTT1 and p53 and urinary transitional cell carcinoma in south-western Taiwan: a preliminary study. Biomarkers 2004; 9: 386-394. (Pubitemid 40100628)
7. Kuroda Y, Tsukino H, Nakao H, Imai H, Katoh T: p53 codon 72 polymorphism and urothelial cancer risk. Cancer Lett 2003; 189: 77-83. (Pubitemid 35351522)
8. Horikawa Y, Nadaoka J, Saito M, Kumazawa T, Inoue T, Yuasa T, Tsuchiya N, Nishiyama H, Ogawa O, Habuchi T: Clinical implications of the MDM2 SNP309 and p53 Arg72Pro polymorphisms in transitional cell carcinoma of the bladder. Oncol Rep 2008; 20: 49-55.
9. Falagas ME, Zarkadoulia EA, Ioannidou EN, Peppas G, Christodoulou C, Rafailidis PI: The effect of psychosocial factors on breast cancer outcome: a systematic review. Breast Cancer Res 2007; 9:R44.
10. Gidron Y, Ronson A: Psychosocial factors, biological mediators, and cancer prognosis: a new look at an old story. Curr Opin Oncol 2008; 20: 386-392.